HC Wainwright & Co. maintains Buy rating on Biodesix, $38 price target
HC Wainwright & Co. maintained their Buy rating on Biodesix's stock with a price target of $38.00.The price target implies an upside of 30.6% from the Sep 25 close of $29.10.Key takeaways from the analyst noteStrong Growth Potential in MRD Strategy: Biodesix has developed a dual approach to molecul…